Stay informed with the latest updates for the inheritable blood disorders community. IndustryNovo's rFVIII Receives Recommendation for EMA Marketing ApprovalOct 1, 2013 IndustryFDA Grants Orphan Drug Status to Alnylam's Hemophilia TherapySep 1, 2013 IndustryBayer Announces 2013 BHAP WinnersAug 1, 2013 IndustryNovo Nordisk Reports Additional Findings from HERO StudyAug 1, 2013 IndustryFDA Gives Priority Review to Gilead's HCV Drug SofosbuvirJul 1, 2013 IndustryFDA Accepts Application for Biogen's Longer-Lasting FVIII ProductJun 1, 2013 IndustryJanssen's HCV Therapy Receives FDA Priority ReviewJun 1, 2013 IndustryBayer Discontinues rFVIIa Therapy TrialJun 1, 2013 IndustryAntiviral Oral Combination Treats Certain HCV PatientsMay 1, 2013 IndustryAchillion Drug Begins Phase 2 Trial in HCV PatientsMay 1, 2013 IndustryGilead Announces HCV Drug Sofosbuvir Clinical Trial ResultsMay 1, 2013 IndustryCSL Donates to WFH GAP ProgramMay 1, 2013 IndustryBaxter Submits FDA Application for Prophylactic FEIBA for Inhibitor…Apr 1, 2013 IndustryPfizer Halts Development of HCV DrugApr 1, 2013 IndustryFDA Accepts Biogen's Application for Longer-Lasting FVIII ProductApr 1, 2013 Pagination First page Previous page … Page 14 Page 15 Page 16 Page 17 Current page 18 Page 19 Page 20 Page 21 Page 22 … Next page Last page
